Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Distribution of EQ-5D-3L responses by dimension and age group

From: Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age

Parameter

Total

Age group

Proportion in %

Dimension

Level

N

18–24

25–34

35–44

45–54

55–64

65–74

75–84

85+

Mobility

No problems

1,074,533

92.7

92.0

88.2

82.0

73.2

63.6

45.5

23.1

Some problems

362,930

4.9

5.7

9.3

15.6

24.5

33.6

51.0

72.5

Confined to bed

4545

0.3

0.3

0.2

0.2

0.2

0.2

0.5

1.7

Self-care

No problems

1,307,043

95.6

95.5

93.8

91.4

88.8

86.2

79.9

64.7

Some problems

118,593

2.0

2.2

3.7

6.0

8.4

10.2

14.3

25.0

Unable to

11,759

0.4

0.4

0.4

0.4

0.5

0.7

1.6

5.5

Usual activities

No problems

1,061,308

88.1

87.9

83.6

77.8

71.6

66.3

51.3

30.4

Some problems

332,279

8.9

9.2

12.8

18.0

23.7

27.9

38.5

49.6

Unable to

47,921

0.9

1.0

1.5

2.2

2.8

3.4

6.5

15.6

Pain/Discomfort

No

780,144

73.1

76.3

68.8

58.5

49.2

40.8

29.9

22.6

Moderate

571,456

17.5

19.8

25.6

33.7

41.6

49.0

57.5

63.1

Extreme

84,005

1.3

1.7

3.2

5.4

7.0

7.2

8.4

9.6

Anxiety/Depression

Not

1,057,588

78.6

77.7

74.4

70.7

70.8

71.9

66.8

59.3

Moderately

314,019

16.1

17.2

19.4

22.3

22.5

20.9

23.4

29.5

Extremely

38,506

2.7

2.6

3.2

3.7

3.0

1.5

1.4

2.1